The global Antibody-Drug Conjugates (ADCs) market size is expected to reach USD 20.01 Billion at a steady revenue CAGR of 25.8% in 2028, according to latest analysis by Emergen Research. Increasing prevalence of cancer along with growing geriatric population is driving antibody-drug conjugates market revenue growth. Antibody drug conjugates are used to treat cancer and are safer than other types of cancer therapies.

Antibody-drug conjugates are highly targeted therapies that use biopharmaceutical drugs comprising monoclonal antibodies to target tumor cell specific antigens and extremely potent anti-cancer drugs linked through chemical linker. ADCs are considered a powerful and highly effective class of therapeutic agents used in oncology and hematology. ADC technology is also used outside of cancer-related indications.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/754

ADCs are a targeted approach to deliver medicine and chemotherapy agents to cancer cells. Almost 8.2 million persons die each year due to cancer globally. Increasing prevalence of cancer in countries across the globe has created a rapid incline in demand for ADCs. Market players are collaborating to share resources and product knowledge to enhance effectiveness and efficiency of solutions and offerings and to develop even more advanced and effective drugs and therapies.  

High cost and stringent regulations are some key factors hampering market growth. Disadvantages of ADCs include challenges of linker technology because synthesis/design of bio-functional is quite challenging due to requirements of specialized teams. ADC must be manufactured in an aseptic environment and operating personnel should be protected from very toxic drug compounds, thus presenting operational difficulties.

The Global Antibody-Drug Conjugates (ADCs) Market report assesses the historical and current data along with a thorough analysis of the market dynamics. The report also sheds light on the significant market growth driving and restraining factors that are anticipated to influence the market growth through the forecast period. The Global Antibody-Drug Conjugates (ADCs) Market studies the market scenario to offer growth projections for the Antibody-Drug Conjugates (ADCs) Market industry for the forecast period of 2021-2028. The report focuses on potential growth opportunities and limitations the prominent players of the industry might face during the entirety of the forecast timeline.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/754

Emergen Research has segmented the global Antibody-Drug Conjugates market on the basis of technology, application, end-use, and region:

Technology Outlook (Revenue, USD Billion; 2018–2028)

Cleavable Linker

Non-Cleavable Linker

Application Outlook (Revenue, USD Billion; 2018–2028)

Blood Cancer

Leukemia

Lymphoma

Brain Tumor

Ovarian Cancer

Breast Cancer

Lung Cancer

Others

End-use Outlook (Revenue, USD Billion; 2018–2028)

Hospitals

Research Institute

Clinics

To know more about the report, visit @ https://www.emergenresearch.com/industry-report/antibody-drug-conjugates-market

Competitive Terrain:

The Global Antibody-Drug Conjugates (ADCs) Market is highly consolidated due to the presence of a large number of companies across this industry. The report discusses the current market standing of these companies, their past performances, demand and supply graph, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market at length. The report scrutinizes the strategic approach of key market players towards expanding their product offerings and fortifying their market foothold.

Key players involved in the market, such as Oxford BioTherapeutics, Bayer AG, Immunomedics Inc., Concortis Biotherapeutics, F. Hoffman-La Roche Ltd., Pfizer Inc., ImmunoGen Inc., AbbVie Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Regional Analysis:

This section of the report offers valuable insights into the geographical segmentation of the Antibody-Drug Conjugates (ADCs) market, alongside estimating the current and future market valuations based on the demand-supply dynamics and pricing structure of the leading regional segments. Furthermore, the growth prospects of each segment and sub-segment have been meticulously described in the report.

The report classifies the global Antibody-Drug Conjugates (ADCs) market into various regions, including:

North America (U.S., Canada)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Middle East Africa (Saudi Arabia, the U.A.E., South Africa, Rest of MEA)

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/754

Thank you for reading our report. Please get in touch with us if you have any queries regarding the report or its customization. Our team will ensure the report is best suited to your needs.

Take a Look at our other Reports:

wireless brain sensor market @ https://www.emergenresearch.com/industry-report/wireless-brain-sensor-market

animal ultrasound market @ https://www.emergenresearch.com/industry-report/animal-ultrasound-market

smart buildings market @ https://www.emergenresearch.com/industry-report/smart-buildings-market

maritime autonomous surface ships market @ https://www.emergenresearch.com/industry-report/maritime-autonomous-surface-ships-market

simulation software market @ https://www.emergenresearch.com/industry-report/simulation-software-market

4d printing market @ https://www.emergenresearch.com/industry-report/4d-printing-market

Light Therapy Market @ https://www.emergenresearch.com/industry-report/light-therapy-market

Trade Management Market @ https://www.emergenresearch.com/industry-report/trade-management-market

About Us:

At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Read Full Press Release @ https://www.emergenresearch.com/press-release/global-antibody-drug-conjugates-market